Literature DB >> 14684324

The design and synthesis of a novel quinolizidine template for potent opioid and opioid receptor-like (ORL1, NOP) receptor ligands.

Ling Jong1, Nurulain Zaveri, Lawrence Toll.   

Abstract

A new class of high affinity opioid and opioid receptor-like receptor (ORL1 receptor, NOP receptor) ligands has been designed by conformational restriction of piperidine-based NOP receptor ligands, resulting in a novel quinolizidine scaffold. Different modifications of the pendant functional groups on the scaffold provide differential activities at the opioid and NOP receptors. While the conformational rigidity will provide an improved understanding of the NOP and opioid receptor binding pockets, these compounds also provide a new template for the design of novel opiate and NOP ligands.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14684324      PMCID: PMC3851569          DOI: 10.1016/j.bmcl.2003.09.068

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  28 in total

1.  High-affinity, non-peptide agonists for the ORL1 (orphanin FQ/nociceptin) receptor.

Authors:  S Röver; G Adam; A M Cesura; G Galley; F Jenck; F J Monsma; J Wichmann; F M Dautzenberg
Journal:  J Med Chem       Date:  2000-04-06       Impact factor: 7.446

2.  Studies on the antinociceptive effect of [Nphe1]nociceptin(1-13)NH2 in mice.

Authors:  A Di Giannuario; A Rizzi; S Pieretti; R Guerrini; R Bertorelli; S Salvadori; D Regoli; G Calo
Journal:  Neurosci Lett       Date:  2001-12-04       Impact factor: 3.046

3.  N-terminal modifications leading to peptide ORL1 partial agonists and antagonists.

Authors:  A K Judd; A Kaushanskaya; D J Tuttle; A Sanchez; T Khroyan; W Polgar; L Toll
Journal:  J Pept Res       Date:  2003-11

Review 4.  Pharmacological profile of nociceptin/orphanin FQ receptors.

Authors:  Girolamo Calo'; Anna Rizzi; Raffaella Bigoni; Remo Guerrini; Severo Salvadori; Domenico Regoli
Journal:  Clin Exp Pharmacol Physiol       Date:  2002-03       Impact factor: 2.557

5.  4-Aminoquinolines: novel nociceptin antagonists with analgesic activity.

Authors:  H Shinkai; T Ito; T Iida; Y Kitao; H Yamada; I Uchida
Journal:  J Med Chem       Date:  2000-11-30       Impact factor: 7.446

6.  Pharmacological profiles of a novel opioid receptor-like1 (ORL(1)) receptor antagonist, JTC-801.

Authors:  Hideki Yamada; Hiromitsu Nakamoto; Yasunori Suzuki; Takao Ito; Kazuo Aisaka
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

7.  [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.

Authors:  Girolamo Calo; Anna Rizzi; Daniela Rizzi; Raffaella Bigoni; Remo Guerrini; Giuliano Marzola; Matteo Marti; John McDonald; Michele Morari; David G Lambert; Severo Salvadori; Domenico Regoli
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

8.  Orphanin FQ/nociceptin attenuates the development of morphine tolerance in rats.

Authors:  K Lutfy; S M Hossain; I Khaliq; N T Maidment
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

9.  Novel hexahydrospiro[piperidine-4,1'-pyrrolo[3,4-c]pyrroles]: highly selective small-molecule nociceptin/orphanin FQ receptor agonists.

Authors:  Sabine Kolczewski; Geo Adam; Andrea M Cesura; François Jenck; Michael Hennig; Thomas Oberhauser; Sonia M Poli; Felix Rössler; Stephan Röver; Jürgen Wichmann; Frank M Dautzenberg
Journal:  J Med Chem       Date:  2003-01-16       Impact factor: 7.446

Review 10.  Peptide and nonpeptide ligands for the nociceptin/orphanin FQ receptor ORL1: research tools and potential therapeutic agents.

Authors:  Nurulain Zaveri
Journal:  Life Sci       Date:  2003-06-27       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.